TYK MEDICINES INC
(HKEX: 2410)
TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the business of research, development and commercialization of pharmaceutical products and differentiated targeted therapies to address unmet medical needs in cancer treatment. The company was founded by Wu Yusheng on November 2, 2017 and is headquartered in Huzhou, China.
12.410 -
-0.040
(-0.32%)
Range
12.140 - 12.560
(3.46%)
Open
12.530
Previous Close
12.450
Bid Price
12.410
Bid Volume
('000)
7.5
Ask Price
12.500
Ask Volume
('000)
34
Volume
('000)
2,458.1
Value
30,307,274
Remark
-
Delayed prices. Updated at 29 Jan 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
